Research

Pihtili, A., Galle, M., Cuhadaroglu, C., Kilicaslan, Z., Issever, H., Erkan, F., … & Gulbaran, Z. (2014). Evidence for the efficacy of a bioresonance method in smoking cessation: a pilot study. Forschende Komplementärmedizin/Research in Complementary Medicine, 21(4), 239-245. 

Prospective randomized, controlled, double-blind clinical trial examining the efficacy of biofield therapy, using the MORA, in helping smokers quit. 190 participants were randomly assigned to bioresonance therapy (95) or simulated bioresonance therapy (95; placebo). Post-treatment, significantly fewer participants in the bioresonance group returned to smoking compared to participants in the placebo group. One year post-treatment, 28.6% of the bioresonance group remained smoke-free compared to 16.1% of the placebo group.

Barassi, Giovanni, et al. “Quantum Medicine and Irritable Bowel Syndrome-Associated Chronic Low-Back Pain: A Pilot Observational Study on the Clinical and Bio-Psycho-Social Effects of Bioresonance Therapy.” Medicina 60.7 (2024): 1099.

Pilot, first-look study to examine whether biofield therapy would have any effect on hospital patients with irritable bowel syndrome (IBS). 20 participants received treatment with the Rayocomp PS 1000 Polar 4.0 Med. There was no control group. Biofield therapy significantly improved a wide range of symptoms, though further studies are needed to validate these findings and tease out placebo effects and regression to the mean.

Muresan, D., Salcudean, A., Sabau, D. C., Bodo, C. R., & Grecu, I. G. (2021). Bioresonance therapy may treat depression. Journal of medicine and life, 14(2), 238. doi: 10.25122/jml-2021-0008

Retrospective study comparing biofield therapy to pharmacological therapy for 140 hospital patients diagnosed with depression. Participants received biofield therapy with the Mora Nova device, pharmacological treatment, or both. All three treatments significantly improved scores on the Hamilton Depression Scale, though the authors did not test for which treatment lessened depression symptoms the most. Based on Figure 1, no treatment group seemed to improve significantly more than the others.

Machowinski, R., and P. Kreisi. “Prospective randomised study to check the results of treatment using endogenous electromagnetic fields, in the case of slight liver cell damage.” (1999).

Preliminary experiment examining biofield therapy as a treatment for minor liver damage. Twenty-eight participants were divided into an experimental group, which received biofield therapy with a BICOM, and an unspecified control group. The experimenters measured blood levles of the liver enzymes glutamate-pyruvate-transaminase, glutamate-oxalacetate-transaminase, and gamma-glutamyl-transferase at baseline, four weeks, eight weeks, and twelve weeks post-treatment. At follow-up, participants in the experimental group had significantly lower levels of the liver enzymes, signalling greater healing. Since it is unclear what kind of control group the researchers use, at best, we can surmise that biofield therapy improved enzyme levels compared to no treatment.

Badtieva, V. A., Pavlov, V. I., Khokhlova, M. N., & Pachina, A. V. (2018). Primenenie biorezonansnoĭ terapii v korrektsii sindroma peretrenirovannosti sportsmena [The application of bioresonance therapy for the correction of the overtrained athlete syndrome]. Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury, 95(6), 51–57. 

(Abstract Only, stay tuned for full text translation). Pilot experiment examining whether biofield therapy can help athletes with overtraining syndrome recover. 60 participants were assigned to receive biofield therapy or placebo treatment from a faulty machine. Following treatment, participants who received biofield therapy showed significantly healthier heart and circulatory activity, suggesting biofield therapy might accelerate recovery.

Nienhaus, J., & Galle, M. (2006). Placebo-controlled study of the effects of a standardized MORA bioresonance therapy on functional gastrointestinal complaints. Forschende Komplementarmedizin (2006), 13(1), 28-34.. 

(Abstract Only, stay tuned for full text translation). Small randomized controlled trial examining whether biofield therapy might less gastrointestinal complaints. 20 participants were randomly assigned to receive biofield therapy from a MORA or placebo. Participants who received biofield therapy reported fewer gastrointestinal complaints, less stomach pain, and less meteorism compared to the placebo group. While the sample size is small, if these results are replicated in a larger study, we could surmise that biofield therapy can aid in alleviating GI distress.